NK Cell Lectin-Like Receptor Subfamily C
"NK Cell Lectin-Like Receptor Subfamily C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.
| Descriptor ID |
D055654
|
| MeSH Number(s) |
D12.776.543.750.705.895.800.810
|
| Concept/Terms |
NK Cell Lectin-Like Receptor Subfamily C- NK Cell Lectin-Like Receptor Subfamily C
- NK Cell Lectin Like Receptor Subfamily C
- Killer Cell Lectin-Like Receptor Subfamily C
- Killer Cell Lectin Like Receptor Subfamily C
- Natural Killer Cell Lectin-Like Receptor Subfamily C
- Natural Killer Cell Lectin Like Receptor Subfamily C
NK Cell Lectin-Like Receptor Subfamily C, Member 2- NK Cell Lectin-Like Receptor Subfamily C, Member 2
- NK Cell Lectin Like Receptor Subfamily C, Member 2
- NKG2C Receptor
- Receptor, NKG2C
- NKG2-C Receptor
- NKG2 C Receptor
- Receptor, NKG2-C
- Killer Cell Lectin-Like Receptor Subfamily C, Member 2
- Killer Cell Lectin Like Receptor Subfamily C, Member 2
- NK Cell Receptor C
NK Cell Lectin-Like Receptor Subfamily C, Member 4- NK Cell Lectin-Like Receptor Subfamily C, Member 4
- NK Cell Lectin Like Receptor Subfamily C, Member 4
- NK Cell Receptor F
- NKG2-F Receptor
- NKG2 F Receptor
- Receptor, NKG2-F
- Killer Cell Lectin-Like Receptor Subfamily C, Member 4
- Killer Cell Lectin Like Receptor Subfamily C, Member 4
NK Cell Lectin-Like Receptor Subfamily C, Member 1- NK Cell Lectin-Like Receptor Subfamily C, Member 1
- NK Cell Lectin Like Receptor Subfamily C, Member 1
- NKG2B Receptor
- Receptor, NKG2B
- NKG2A Receptor
- Receptor, NKG2A
- Killer Cell Lectin-Like Receptor Subfamily C, Member 1
- Killer Cell Lectin Like Receptor Subfamily C, Member 1
- NK Cell Receptor A
NK Cell Lectin-Like Receptor Subfamily C, Member 3- NK Cell Lectin-Like Receptor Subfamily C, Member 3
- NK Cell Lectin Like Receptor Subfamily C, Member 3
- NKG2-E Receptor
- NKG2 E Receptor
- Receptor, NKG2-E
- NK Cell Receptor E
- NKG2E Receptor
- Receptor, NKG2E
- Killer Cell Lectin-Like Receptor Subfamily C, Member 3
- Killer Cell Lectin Like Receptor Subfamily C, Member 3
|
Below are MeSH descriptors whose meaning is more general than "NK Cell Lectin-Like Receptor Subfamily C".
Below are MeSH descriptors whose meaning is more specific than "NK Cell Lectin-Like Receptor Subfamily C".
This graph shows the total number of publications written about "NK Cell Lectin-Like Receptor Subfamily C" by people in this website by year, and whether "NK Cell Lectin-Like Receptor Subfamily C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 4 | 2 | 6 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "NK Cell Lectin-Like Receptor Subfamily C" by people in Profiles.
-
Restoring NK cells functionality via cytokine activation enhances cetuximab-mediated NK-cell ADCC: A promising therapeutic tool for HCC patients. Mol Immunol. 2021 09; 137:221-227.
-
Expression of NKG2A inhibitory receptor on cytotoxic lymphocytes as an indicator of severity in Corona Virus Disease 2019 (COVID-19) patients. Egypt J Immunol. 2021 Jul; 28(3):157-167.
-
Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far? Rev Med Virol. 2021 11; 31(6):e2236.
-
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Genet Med. 2021 05; 23(5):963-967.
-
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway. Cells. 2020 08 26; 9(9).
-
The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions. Front Immunol. 2020; 11:1692.
-
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Cell Mol Immunol. 2020 09; 17(9):995-997.
-
NK cells: A double edge sword against SARS-CoV-2. Adv Biol Regul. 2020 08; 77:100737.
-
NKG2A and COVID-19: another brick in the wall. Cell Mol Immunol. 2020 06; 17(6):672-674.
-
A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement. Elife. 2018 12 21; 7.